<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01252121</url>
  </required_header>
  <id_info>
    <org_study_id>RDG-10-275</org_study_id>
    <secondary_id>CS-10-01</secondary_id>
    <nct_id>NCT01252121</nct_id>
  </id_info>
  <brief_title>Residence Time Evaluation of Systane Ultra Lubricant Eye Drops vs. Hialid and Saline</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alcon Research</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alcon Research</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the ocular retention time of Systane Ultra compared
      to Hialid and saline.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ocular surface residence time</measure>
    <time_frame>Time to event</time_frame>
    <description>Ocular surface residence time is defined as the time for fluorescence intensity to return to baseline value after a drop of ophthalmic dye is instilled in the study eye. Dye retention will be measured with a fluorophotometer.</description>
  </primary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Dry Eye Syndrome</condition>
  <arm_group>
    <arm_group_label>Systane, Hialid, Unisol</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>1 drop Systane in study eye at Visit 2, 1 drop Hialid in study eye at Visit 3, 1 drop Unisol in study eye at Visit 4, with a minimum of 24 hours between each visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Systane, Unisol, Hialid</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>1 drop Systane in study eye at Visit 2, 1 drop Unisol in study eye at Visit 3, 1 drop Hialid in study eye at Visit 4, with a minimum of 24 hours between each visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hialid, Systane, Unisol</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>1 drop Hialid in study eye at Visit 2, 1 drop Systane in study eye at Visit 3, 1 drop Unisol in study eye at Visit 4, with a minimum of 24 hours between each visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hialid, Unisol, Systane</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>1 drop Hialid in study eye at Visit 2, 1 drop Unisol in study eye at Visit 3, 1 drop Systane in study eye at Visit 4, with a minimum of 24 hours between each visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unisol, Systane, Hialid</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>1 drop Unisol in study eye at Visit 2, 1 drop Systane in study eye at Visit 3, 1 drop Hialid in study eye at Visit 4, with a minimum of 24 hours between each visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Unisol, Hialid, Systane</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>1 drop Unisol in study eye at Visit 2, 1 drop Hialid in study eye at Visit 3, 1 drop Systane in study eye at Visit 4, with a minimum of 24 hours between each visit.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Systane Ultra Lubricant Eye Drops</intervention_name>
    <description>One drop in study eye, one time, during office visit.</description>
    <arm_group_label>Systane, Hialid, Unisol</arm_group_label>
    <arm_group_label>Systane, Unisol, Hialid</arm_group_label>
    <arm_group_label>Hialid, Systane, Unisol</arm_group_label>
    <arm_group_label>Hialid, Unisol, Systane</arm_group_label>
    <arm_group_label>Unisol, Systane, Hialid</arm_group_label>
    <arm_group_label>Unisol, Hialid, Systane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hialid 0.1 Artificial Tears Eye Drops</intervention_name>
    <description>One drop in study eye, one time, during office visit.</description>
    <arm_group_label>Systane, Hialid, Unisol</arm_group_label>
    <arm_group_label>Systane, Unisol, Hialid</arm_group_label>
    <arm_group_label>Hialid, Systane, Unisol</arm_group_label>
    <arm_group_label>Hialid, Unisol, Systane</arm_group_label>
    <arm_group_label>Unisol, Systane, Hialid</arm_group_label>
    <arm_group_label>Unisol, Hialid, Systane</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Unisol 4 Saline Solution</intervention_name>
    <description>One drop in study eye, one time, during office visit.</description>
    <arm_group_label>Systane, Hialid, Unisol</arm_group_label>
    <arm_group_label>Systane, Unisol, Hialid</arm_group_label>
    <arm_group_label>Hialid, Systane, Unisol</arm_group_label>
    <arm_group_label>Hialid, Unisol, Systane</arm_group_label>
    <arm_group_label>Unisol, Systane, Hialid</arm_group_label>
    <arm_group_label>Unisol, Hialid, Systane</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Diagnosed with mild to moderate dry eye as defined in the protocol.

          -  Able and willing to follow instructions.

          -  Other protocol-defined inclusion criteria may apply.

        Exclusion Criteria:

          -  Any medical condition that may affect the results of the study.

          -  History or evidence of ocular or intraocular surgery within the past six months.

          -  History of intolerance or hypersensitivity to any component of the study medications.

          -  Use of concomitant topical ocular medications during the study period.

          -  Ocular conditions that may preclude safe administration of the test article.

          -  Unwilling to discontinue contact lens wear during the study period.

          -  Participation in an investigational drug or device study within 30 days of enrollment.

          -  Other protocol-defined exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <removed_countries>
    <country>United States</country>
  </removed_countries>
  <verification_date>May 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2010</study_first_submitted>
  <study_first_submitted_qc>December 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 2, 2010</study_first_posted>
  <last_update_submitted>October 26, 2012</last_update_submitted>
  <last_update_submitted_qc>October 26, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 30, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Dry Eye</keyword>
  <keyword>Ocular Retention Time</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dry Eye Syndromes</mesh_term>
    <mesh_term>Keratoconjunctivitis Sicca</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ophthalmic Solutions</mesh_term>
    <mesh_term>Tetrahydrozoline</mesh_term>
    <mesh_term>Lubricant Eye Drops</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

